You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Healthy Control subjects

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypoglycemia, Diabetes, Type 1 Trial in Aarhus (Glucose clamp technique)

Completed
  • Hypoglycemia
  • Diabetes Mellitus, Type 1
  • Glucose clamp technique
  • Aarhus, Denmark
    Department of Clinical Medicine
Oct 4, 2022

Moderate Hepatic Impairment Trial in Miami, Orlando (Mitapivat)

Recruiting
  • Moderate Hepatic Impairment
  • Miami, Florida
  • +1 more
Jan 11, 2023

COPD Trial in Sofia (CHF6001)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Sofia, Bulgaria
    MC Comac Medical Ltd.
May 16, 2022

Cardiovascular and Cerebrovascular Control in Healthy Subjects

Not yet recruiting
  • Healthy
  • +2 more
  • active standing
  • San Donato Milanese, Milan, Italy
    Vlasta Bari
Jan 31, 2023

COPD Trial (CH6001)

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • (no location specified)
Jul 19, 2022

Renal Impairment, Renal Disease, Kidney Disease Trial in Miami Lakes, Orlando (Nitazoxanide)

Completed
  • Renal Impairment
  • +2 more
  • Miami Lakes, Florida
  • +1 more
Oct 27, 2022

Healthy Volunteers Trial in Tempe (Epetraborole and matching , Epetraborole, Placebo)

Active, not recruiting
  • Healthy Volunteers
  • Epetraborole and matching placebo
  • +3 more
  • Tempe, Arizona
    423001
Aug 16, 2023

Poor Quality Sleep Trial in Murcia (Botanical ingredient, Control group)

Active, not recruiting
  • Poor Quality Sleep
  • Botanical ingredient
  • Control group
  • Murcia, Spain
    Catholic University of Murcia
Dec 1, 2023

Moderate Hepatic Impairment, Severe Hepatic Impairment, Liver Diseases Trial in Miami Lakes, Orlando (Nitazoxanide)

Completed
  • Moderate Hepatic Impairment
  • +2 more
  • Miami Lakes, Florida
  • +1 more
Oct 12, 2022

Healthy Trial in Beijing (MT200605 for Injection, MT200605 Placebo)

Enrolling by invitation
  • Healthy
  • MT200605 for Injection
  • MT200605 Placebo
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Jul 13, 2023

Cardiac Repolarization Trial in Melbourne (Placebo, Moxifloxacin (positive control), Milademetan)

Not yet recruiting
  • Cardiac Repolarization
  • Placebo
  • +2 more
  • Melbourne, Victoria, Australia
    Nucleus Network Melbourne
Mar 6, 2023

Herpes Zoster Trial in Xinxiang (Low dose Recombinant Herpes Zoster Vaccine (CHO cells), High dose Recombinant Herpes Zoster

Not yet recruiting
  • Herpes Zoster
  • Low dose Recombinant Herpes Zoster Vaccine (CHO cells)
  • +3 more
  • Xinxiang, Henan, China
    Yanjin Center for Disease Control and Prevention
May 4, 2023

Seasonal Influenza Trial in China (Quadrivalent influenza vaccine(0.25ml), Quadrivalent influenza vaccine(0.5ml), Trivalent

Not yet recruiting
  • Seasonal Influenza
  • Quadrivalent influenza vaccine(0.25ml)
  • +3 more
  • Lu'an, Anhui, China
  • +4 more
Sep 15, 2023

Idiopathic Pulmonary Fibrosis Trial in Shanghai (SC1011, Placebo tablet)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Shanghai, Shanghai, China
    Shanghai Xuhui District Central Hospital
Nov 14, 2023

Metabolomic Analysis of Systemic Sclerosis

Recruiting
  • Scleroderma (Limited and Diffuse)
  • +4 more
  • - Skin biopsy - Urine sample - Blood sample
  • Dijon, France
  • +3 more
Jul 7, 2022

Herpes Zoster Trial in Xinxiang (Low Dose Recombinant Herpes Zoster Vaccine (CHO cells), High Dose Recombinant Herpes Zoster

Active, not recruiting
  • Herpes Zoster
  • Low Dose Recombinant Herpes Zoster Vaccine (CHO cells)
  • +5 more
  • Xinxiang, Henan, China
    Yanjin District Center for Disease Control and Prevention
Feb 1, 2023

Cadmium Exposure Trial in Changsha (GMDTC for injection, Normal saline)

Recruiting
  • Cadmium Exposure
  • GMDTC for injection
  • Normal saline
  • Changsha, Hunan, China
    Hunan Occupational Disease Prevention and Control Institute
Jun 9, 2023

Healthy Trial (Iclepertin, Iclepertin Placebo, Moxifloxacin)

Not yet recruiting
  • Healthy
  • (no location specified)
Oct 2, 2023

Healthy Trial (BI 1015550, Moxifloxacin, Placebo)

Not yet recruiting
  • Healthy
  • BI 1015550
  • +2 more
  • (no location specified)
Nov 2, 2023

Healthy Subjects Trial (Test Formula, Control Formula)

Not yet recruiting
  • Healthy Subjects
  • Test Formula
  • Control Formula
  • (no location specified)
Nov 7, 2023

Healthy Trial in Barcelona (Tramadol.)

Recruiting
  • Healthy
  • Barcelona, Spain
    IMIM (Institut Hospital del Mar d'Investigacions Mèdiques)
Jun 27, 2023

Diabetes, Type 2 Trial in Lincoln (GZR-18, Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • Lincoln, Nebraska
    Celerion
Dec 21, 2022

Peripheral Arterial Disease, Diabetes Trial in New Haven (SPECT/CT imaging following revascularization procedures, SPECT/CT

Recruiting
  • Peripheral Arterial Disease
  • Diabetes Mellitus
  • SPECT/CT imaging following revascularization procedures
  • SPECT/CT imaging
  • New Haven, Connecticut
    Yale-New Haven Hospital
May 13, 2022

Renal Disease, End Stage Trial in Miami Lakes (Amisulpride IV, Amisulpride Oral Tablet)

Completed
  • Renal Disease, End Stage
  • Amisulpride IV
  • Amisulpride Oral Tablet
  • Miami Lakes, Florida
    Panax Clinical Research
Dec 10, 2021

Healthy Trial (Placebo, PRS-220)

Not yet recruiting
  • Healthy
  • (no location specified)
Jul 21, 2022